Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for type 2 diabetes.

M M Engelgau1, K M Narayan, W H Herman

  • 1Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. mxe1@cdc.gov

Diabetes Care
|October 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare utilisation and expenditure patterns for cardio-metabolic diseases in South Asian cities: the CARRS Study.

BMJ open·2020
Same author

Ethnic differences in the prevalence of diabetes in underweight and normal weight individuals: The CARRS and NHANES studies.

Diabetes research and clinical practice·2018
Same author

Diabetes and ischaemic stroke outcome.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Effect of lifestyle improvement program on the biomarkers of adiposity, inflammation and gut hormones in overweight/obese Asian Indians with prediabetes.

Acta diabetologica·2017
Same author

Mysteries of type 2 diabetes: the Indian Elephant meets the Chinese Dragon.

European journal of clinical nutrition·2017
Same author

Addressing noncommunicable diseases in primary care: the case of type 2 diabetes.

The journal of the Royal College of Physicians of Edinburgh·2017
Same journal

Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

Diabetes care·2026
Same journal

A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

Diabetes care·2026
Same journal

Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

Diabetes care·2026
Same journal

Proteomic Signatures of 3-Year Progression From Impaired Fasting Glucose to Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.

Diabetes care·2026
Same journal

Melatonin Impairs Glucose Tolerance, First-Phase Insulin Secretion, and Insulin Feedback Inhibition; Interaction With MTNR1B Diabetes Risk Variant.

Diabetes care·2026
Same journal

Automated Insulin Delivery: Great Strides in the Past, Great Needs for the Future.

Diabetes care·2026
See all related articles

Definitive studies on type 2 diabetes screening effectiveness are lacking. Observational studies and refined statistical models are needed to assess screening benefits and optimize approaches for early detection and treatment.

Area of Science:

  • Public Health
  • Epidemiology
  • Health Services Research

Background:

  • Definitive studies evaluating the effectiveness of screening for type 2 diabetes are not currently available.
  • Randomized controlled trials (RCTs), the gold standard for effectiveness assessment, face significant barriers to implementation.
  • Prospective observational studies offer a potential alternative for characterizing screening benefits by comparing screened and unscreened populations.

Purpose of the Study:

  • To review the current state of type 2 diabetes screening effectiveness research.
  • To identify challenges and potential strategies for improving screening methodologies and data analysis.
  • To highlight areas for future research, including the development of refined statistical models and economic evaluations.

Main Methods:

Related Experiment Videos

  • Evaluation of various screening tests, including risk assessment questionnaires and biochemical tests (venous/capillary glucose, HbA1c).
  • Discussion of screening strategies such as two-stage testing and optimal screening intervals.
  • Review of the role of statistical modeling and the need for improved data systems and health services research techniques.

Main Results:

  • Risk assessment questionnaires show poor performance as stand-alone screening tools.
  • Biochemical tests, particularly venous/capillary glucose measurements (postprandial preferred), demonstrate better performance than urinary glucose or HbA1c.
  • No well-defined, validated cutoff points currently exist for positive screening tests, and optimal screening intervals remain unknown.

Conclusions:

  • Periodic, targeted screening within healthcare systems appears most promising for yield and follow-up.
  • Refined statistical models incorporating new clinical data and natural history of preclinical diabetes are essential.
  • Future research should focus on comprehensive evaluations, including cost-effectiveness, quality of life, and combinations of screening tests and intervals.